Lung Cancer

Collecting data about cancer through registries can help experts detect trends and patterns, leading to better care for patients.

The Food and Drug Administration approved Rozlytrek (entrectinib) for adult and adolescent patients 12 years of age and older whose cancers have the NTRK gene fusion and for adults with non-small cell lung cancer whose tumors are ROS1-positive and have spread to other parts of the body.

Progress in cancer comes slowly, in bits and pieces and not in sudden bursts of success. And even when “breakthroughs” happen, it usually takes a long time to confirm that the early results actually make a difference.

The earlier lung cancer is detected, the better chance a person has of surviving the disease. Knowing the risk factors and statistics will help you to understand how you can minimize your possibility of developing the disease.

Here is a list of the recent trial initiations that occurred within the cancer space in July.

Sometimes in life, we are fortunate enough to meet an individual who inspires us, motivating us to be our best. I was fortunate to meet Valerie “Val” Betancourt, M.S.N., RN, NP-C, OCN, over 20 years ago. Little did I know this was going to be the beginning of a wonderful friendship.
 

From landmark Senate legislation to the Pink Lemonade Stand Challenge, here’s what is making headlines in the cancer space this week.

GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress for her leadership in lung cancer research.

GO₂ Foundation will recognize Prof. Peters at the 20^th International Lung Cancer Congress for her leadership in lung cancer research.